Genetic Marker Analysis for Medication Effectiveness Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medication prescription methods do not effectively account for individual genetic variations, leading to ineffective treatments and unnecessary side effects due to the historical effectiveness-based approach, which can result in resource wastage and suboptimal therapeutic outcomes.

Innovation Solution

A system and method that utilizes genetic data to determine the effectiveness of medications by identifying genetic markers through sequencing, comparing them against known medication responses, and suggesting alternative treatments or dosages, with results integrated into healthcare providers' systems for informed decision-making.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If medication prescription is based on historical effectiveness, then treatment coverage is broad, but individual treatment effectiveness deteriorates due to genetic variations

Engineering Contradiction:
Improveindividual treatment effectivenessVSAvoidprescription system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system performs genetic testing and determines medication effectiveness in advance before prescription. Genetic material is collected, tested for relevant markers, and effectiveness predictions are generated beforehand, allowing healthcare providers to select effective medications from the start rather than relying on trial-and-error approaches.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system introduces an intermediary layer between traditional prescription practices and patient treatment. This intermediary consists of the genetic testing system that analyzes genetic markers and provides effectiveness predictions, mediating the decision-making process to bridge general medical knowledge and individual patient responses.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If genetic testing is implemented to determine medication effectiveness, then individual treatment precision is improved, but resource consumption increases due to testing costs and processing requirements

Engineering Contradiction:
Improvemedication effectiveness prediction accuracyVSAvoidresource consumption
Core Design Contradiction:
Measurement precisionVSLoss of energy

Solution Approach 1:

The system extracts only the necessary genetic information for medication effectiveness prediction. Rather than analyzing the entire genome, it focuses on collecting and testing only relevant genetic markers associated with medication response, thereby reducing the resource investment required while maintaining prediction accuracy.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system changes the parameters of genetic testing by focusing on specific markers rather than comprehensive genomic analysis. By identifying and testing only the relevant genetic parameters associated with medication metabolism and response, the system achieves precise predictions with reduced resource consumption.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If comprehensive genetic testing is performed, then medication effectiveness determination is accurate, but testing time and complexity increase

Engineering Contradiction:
Improveeffectiveness determination accuracyVSAvoidtesting time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system extracts and tests only the essential genetic markers necessary for medication effectiveness determination. By identifying a focused set of relevant markers rather than performing comprehensive genomic sequencing, the system achieves accurate predictions in a fraction of the time required for full genome analysis.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS11527331B2System and method for determining the effectiveness of medications using genetics
Publication Date: 2022.12.13 XACT LABORATORIES LLC
  • US11527331B2 patent drawing
  • US11527331B2 patent drawing
  • US11527331B2 patent drawing

AI summary

A system and method for alerting a healthcare provider to ineffective prescribed medications is provided. A laboratory system receives test results with genetic markers for a patient, queries a database containing medications known to be ineffective in persons having particular genetic markers to determine whether any medications prescribed by, or likely to be prescribed by, a healthcare provider to the patient are known to be ineffective in persons having the same genetic markers as the patient, and transmits an alert containing such information to a healthcare provider system for the healthcare provider.